Matchpoint Therapeutics
Cambridge
About Matchpoint Therapeutics
Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry library evolution. Matchpoint has an emerging pipeline of novel covalent medicines, initially focused on immunology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $100.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2022)
- Website: matchpointtx.com
- Phone: 617-620-6280
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/matchpoint-therapeutics-27562 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.